Samsung Biologics pays GSK $280M to secure first US manufacturing site
Already boasting an outsized presence in its home country of South Korea, CDMO juggernaut Samsung Biologics is making…
Contractor SK Pharmteco heralds completion of 2 API plants in Ireland
The summer of the high-potency active pharmaceutical ingredient (HPAPI) expansion continues, as yet another manufacturing specialist makes inroads…
Samsung Bio ekes ahead of Korea biopharma peers with stellar 2025
As Samsung Biologics’ contract manufacturing business continues to fire on all cylinders, the CDMO has earned a unique…